Back
ESC Premium Access

Effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, on diuresis and neurohormonal activation in type 2 diabetes mellitus and heart failure

Session: Novel pharmacological therapy in chronic heart failure
Topic: Pharmacologic therapy
Speaker: Doctor T. Takeuchi (Tsu, JP)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Tetsushiro Takeuchi

Mie University Graduate School of Medicine, Tsu (Japan)
0 follower

6 more presentations in this session

Contribution of central donepezil to prevention of cardiac dysfunction and improvement of long-term survival in chronic heart failure rats after myocardial infarction

Speaker: Doctor M. Li (Osaka, JP)

Access
Abstract
Slides
Thumbnail

Stimulation of the soluble guanylate cyclase attenuates pressure-overload induced cardiac hypertrophy in mice

Speaker: Doctor J. Ruedebusch (Greifswald, DE)

Access
Abstract
Thumbnail

Magnesium orotate improves symptoms, exercise capacity and quality of life in patients with valve prosthesis: results from a randomized, open-label, case-control 2-year study

Speaker: Professor I. Gaisin (Izhevsk, RU)

Access
Abstract
Slides
Thumbnail

Get the right balance: a novel vasopressin receptor antagonist equally blocks human V1a and V2 receptors and inhibits the release of plasminogen activator inhibitor-1 from cardiomyocytes

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Access
Abstract
Slides
Thumbnail

The CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo

Speaker: Mr J. Mustroph (Regensburg, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Novel pharmacological therapy in chronic heart failure

Speakers: Doctor T. Takeuchi, Doctor M. Li, Doctor J. Ruedebusch, Professor I. Gaisin, Doctor P. Kolkhof...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb